Neurocrine Biosciences is a leading biopharmaceutical company focused on neuroscience, dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. With a strong commitment to relieving suffering for those in need, the company boasts a diverse portfolio of FDA-approved treatments and a robust pipeline of compounds in clinical development. Neurocrine fosters an inclusive and positive workplace culture, emphasizing collaboration, integrity, and innovation. Recognized as one of the FORTUNE Best Workplaces in Biopharma™ 2024, Neurocrine is driven by a passion for making a difference and is committed to the well-being of its employees and the communities it serves.